vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and OLYMPIC STEEL INC (ZEUS). Click either name above to swap in a different company.
OLYMPIC STEEL INC is the larger business by last-quarter revenue ($490.7M vs $284.0M, roughly 1.7× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 0.4%, a 95.9% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 4.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 0.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Olympic Steel, Inc. is a metals service center based in Cleveland, Ohio. The company processes and distributes carbon, coated and stainless flat-rolled sheet, coil and plate steel, aluminium alloy, tin plate, and metal-intensive branded products primarily in the United States. Metals processing and value added services include tempering, stretch leveling, cutting-to-length, slitting, edging, shearing, blanking, burning, forming, shot blasting, laser punching, plate rolling, fabricating, machi...
ACAD vs ZEUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $490.7M |
| Net Profit | $273.6M | $2.2M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 1.5% |
| Net Margin | 96.3% | 0.4% |
| Revenue YoY | 9.4% | 4.4% |
| Net Profit YoY | 90.3% | -21.2% |
| EPS (diluted) | $1.61 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $490.7M | ||
| Q2 25 | $264.6M | $496.5M | ||
| Q1 25 | $244.3M | $492.9M | ||
| Q4 24 | $259.6M | $418.8M | ||
| Q3 24 | $250.4M | $470.0M | ||
| Q2 24 | $242.0M | $526.3M | ||
| Q1 24 | $205.8M | $526.6M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $2.2M | ||
| Q2 25 | $26.7M | $5.2M | ||
| Q1 25 | $19.0M | $2.5M | ||
| Q4 24 | $143.7M | $3.9M | ||
| Q3 24 | $32.8M | $2.7M | ||
| Q2 24 | $33.4M | $7.7M | ||
| Q1 24 | $16.6M | $8.7M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 1.5% | ||
| Q2 25 | 12.2% | 2.3% | ||
| Q1 25 | 7.9% | 1.6% | ||
| Q4 24 | 59.1% | 2.1% | ||
| Q3 24 | 12.6% | 1.7% | ||
| Q2 24 | 12.6% | 2.9% | ||
| Q1 24 | 7.4% | 3.0% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 0.4% | ||
| Q2 25 | 10.1% | 1.1% | ||
| Q1 25 | 7.8% | 0.5% | ||
| Q4 24 | 55.4% | 0.9% | ||
| Q3 24 | 13.1% | 0.6% | ||
| Q2 24 | 13.8% | 1.5% | ||
| Q1 24 | 8.0% | 1.7% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $0.18 | ||
| Q2 25 | $0.16 | $0.45 | ||
| Q1 25 | $0.11 | $0.21 | ||
| Q4 24 | $0.86 | $0.33 | ||
| Q3 24 | $0.20 | $0.23 | ||
| Q2 24 | $0.20 | $0.66 | ||
| Q1 24 | $0.10 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $7.5M |
| Total DebtLower is stronger | — | $240.9M |
| Stockholders' EquityBook value | $1.2B | $579.1M |
| Total Assets | $1.6B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $7.5M | ||
| Q2 25 | $253.6M | $14.8M | ||
| Q1 25 | $217.7M | $13.3M | ||
| Q4 24 | $319.6M | $11.9M | ||
| Q3 24 | $155.1M | $11.1M | ||
| Q2 24 | $177.1M | $9.4M | ||
| Q1 24 | $204.7M | $10.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | $240.9M | ||
| Q2 25 | — | $233.2M | ||
| Q1 25 | — | $235.4M | ||
| Q4 24 | — | $272.5M | ||
| Q3 24 | — | $197.3M | ||
| Q2 24 | — | $209.2M | ||
| Q1 24 | — | $196.8M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $579.1M | ||
| Q2 25 | $822.4M | $578.2M | ||
| Q1 25 | $765.2M | $574.2M | ||
| Q4 24 | $732.8M | $573.9M | ||
| Q3 24 | $577.2M | $570.6M | ||
| Q2 24 | $516.7M | $569.5M | ||
| Q1 24 | $464.0M | $563.0M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.2B | $1.0B | ||
| Q3 24 | $976.9M | $1.0B | ||
| Q2 24 | $914.1M | $1.0B | ||
| Q1 24 | $855.1M | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.41× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.35× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-5.4M |
| Free Cash FlowOCF − Capex | — | $-12.9M |
| FCF MarginFCF / Revenue | — | -2.6% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | -0.18× | -2.50× |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $-5.4M | ||
| Q2 25 | $64.0M | $15.5M | ||
| Q1 25 | $20.3M | $49.4M | ||
| Q4 24 | $40.4M | $14.6M | ||
| Q3 24 | $63.2M | $24.6M | ||
| Q2 24 | $25.0M | $-2.9M | ||
| Q1 24 | $29.1M | $-2.6M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $-12.9M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | $63.2M | $15.6M | ||
| Q2 24 | — | $-11.3M | ||
| Q1 24 | — | $-7.4M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | -2.6% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 25.2% | 3.3% | ||
| Q2 24 | — | -2.2% | ||
| Q1 24 | — | -1.4% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | 0.0% | 1.9% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | -2.50× | ||
| Q2 25 | 2.40× | 2.96× | ||
| Q1 25 | 1.07× | 19.70× | ||
| Q4 24 | 0.28× | 3.75× | ||
| Q3 24 | 1.93× | 9.01× | ||
| Q2 24 | 0.75× | -0.38× | ||
| Q1 24 | 1.76× | -0.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
ZEUS
| Carbon Flat Products | $268.2M | 55% |
| Specialty Metals Flat Products | $140.9M | 29% |
| Tubular And Pipe Products | $81.6M | 17% |
